for common recessive conditions, aneuploidy, Plus optional fetal RhD status
99% sensitive. 99% specific. 100% accuracy in clinical studies.
Maternal carrier screen* is performed before reflexing to single-gene NIPT
* fetal sex optional, available for twins
Identifies D antigen incompatibility
* optional and applicable to Rh- mothers only
*Screening for fragile X syndrome (FXS), an X-linked condition, is also available. UNITY™ screens maternal blood to determine the number of CGG repeats she has in her FMR1 gene.
Did You Know
58.5%
of carrier-positive mothers do not follow up with paternal testing
40%
of Rh- women
do not need Anti-D
immunoglobulin
Know early to explore treatments.
There are emerging therapies for conditions previously considered to be untreatable that you may not know about. Identifying high-risk pregnancies early may have a significant impact on baby’s health outcome.
Add Rh(d) NIPT order if applicable
Collect three tubes of maternal blood.
Ship the sample using pre-labeled kit.
Complimentary genetic counseling sessions are available to all patients, before or after taking the test.
All insurances including Medicaid are accepted and financial assistance is available.
We are here for you.
Complimentary genetic counseling is available before or after taking the test. Our board-certified genetic counselors are here to guide you through the process.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
UNITY™ sgNIPT has shown > 98.5% sensitivity and >99% specificity in a peer reviewed publication.
It has also shown 100% concordance with newborn screen results in NIH-sponsored clinical study with Baylor College of Medicine and a study with University of Alabama Birmingham.
Single-Molecule Accuracy Powered by QCT™
Using QCT™ molecular counting technology, UNITY™ is able to differentiate homozygous affected fetus (colored bars) from carrier fetus (gray bar). In addition, UNITY™ performs a paternal allele assay to detect a fetus at-risk to be compound heterozygous for CFTR or HBB at >98% detection rate.
Exemplary Readout. Chromosome 21 Ratio: euploid vs trisomy 21
UNITY™ sgNIPT and Aneuploidy + RhD NIPT use synthetic molecules and computational decoding in the bioinformatics stage to reduce the assay amplification noise down to the theoretical limit. Thanks to these proprietary technologies, UNITY™ can uniquely offer reflex sgNIPT and Rh NIPT solutions.
The world’s only next generation sequencing-based fetal RhD cell-free DNA test
Each assay includes QCT™ (Quantitative Counting Template) controls to ensure the Rh- result is due to the true absence of RHD gene, not an assay failure. Internal clinical study showed 100% accuracy in making Rh- calls.